Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xeris Pharmaceuticals (DE:2B30)
FRANKFURT:2B30
RESEARCH TOOLSreports
Holding DE:2B30?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 54.27M | $ 48.06M | $ 40.64M | $ 48.32M | - |
| Gross Profit | $ 40.67M | $ 40.27M | $ 34.67M | $ 40.12M | - |
| EBIT | $ -19.06M | $ -14.26M | $ -8.95M | $ -5.68M | - |
| EBITDA | $ -15.14M | $ -10.12M | $ -5.32M | $ -2.32M | - |
| Net Income Common Stockholders | $ -15.74M | $ -7.04M | $ -18.98M | $ -12.19M | - |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 69.40M | $ 77.57M | $ 87.35M | $ 65.97M | $ 80.67M |
| Total Assets | $ 321.10M | $ 331.73M | $ 336.62M | $ 327.78M | $ 328.78M |
| Total Debt | $ 270.96M | $ 269.80M | $ 268.69M | $ 227.94M | $ 224.99M |
| Net Debt | $ 201.56M | $ 192.24M | $ 181.34M | $ 161.97M | $ 144.32M |
| Total Liabilities | $ 349.43M | $ 351.02M | $ 345.79M | $ 323.92M | $ 315.14M |
| Stockholders Equity | $ -28.32M | $ -19.28M | $ -9.18M | $ 3.87M | $ 13.69M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -8.39M | $ -10.74M | $ -20.47M | - | - |
| Operating Cash Flow | $ -8.30M | $ -10.35M | $ -20.30M | - | - |
| Investing Cash Flow | $ 9.91M | $ 4.60M | $ -19.65M | - | - |
| Financing Cash Flow | $ -83.00K | $ 659.00K | $ 35.19M | - | - |